Press "esc" to clear
Go to Advanced Search

Showing results

110 of 50

Article ID: 694263

UAB Celebrates 50th Anniversary of First Transplant in Alabama

University of Alabama at Birmingham

Since 1968, UAB Medicine has performed more than 14,000 life-saving organ transplants.

Released:
9-May-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
michigan-med-l-alcoholic-01_0.jpg

Article ID: 694050

Study: Alcohol-Related Cirrhosis Patients are Sicker, Costlier and Often Female

Michigan Medicine - University of Michigan

A new review by Michigan Medicine finds that women drinkers are disproportionately affected in alcohol-related cirrhosis cases. Why — and what's next.

Released:
4-May-2018 8:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Huppert_Nature_livercellswitchingFINAL.jpg
  • Embargo expired:
    2-May-2018 1:00 PM EDT

Article ID: 693717

Liver Fix Thyself

Cincinnati Children's Hospital Medical Center

By studying a rare liver disease called Alagille syndrome, scientists discovered the mechanism behind a form of tissue regeneration that may someday reduce the need for organ transplants. Researchers report in Nature that when disease or injury causes a shortage in one type of liver cell, the organ can instruct another type of liver cell to change identities to provide replacement supplies. The findings one day may lead to a viable treatment for human disease.

Released:
30-Apr-2018 11:50 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 693443

Mayo Clinic的研究发现,移植的肝脏能帮助身体抵御器官排斥反应

Mayo Clinic

Mayo Clinic的研究显示,移植的肝脏改变了受体的血液细胞的状况,减少了器官排斥反应的可能性。 这些发现发表在Kidney International杂志上。

Released:
25-Apr-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
jorge_moscat-2_0.jpg
  • Embargo expired:
    24-Apr-2018 12:00 PM EDT

Article ID: 693148

How Colorectal Cancer Cells Spread to the Liver

Sanford Burnham Prebys Medical Discovery Institute

A new study by Sanford Burnham Prebys Medical Discovery Institute (SBP) researchers helps explain the connection between a tumor suppressor called protein kinase C zeta (PKC zeta) and metastatic colorectal cancer.

Released:
20-Apr-2018 12:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    22-Apr-2018 5:45 PM EDT

Article ID: 692676

Growing Evidence that Probiotics Are Good for Your Liver

Federation of American Societies for Experimental Biology (FASEB)

Increased awareness of the importance of the microbes that live in our gut has spurred a great deal of research on the microbiome and fueled a booming probiotics industry. A new study suggests probiotics can improve not only the health of our gut but liver health, as well.

Released:
16-Apr-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
  • Embargo expired:
    21-Apr-2018 12:35 PM EDT

Article ID: 692657

New Leads in the Development and Treatment of Liver Disease

Federation of American Societies for Experimental Biology (FASEB)

A treatment gap remains for many conditions involving damage to the liver, the body’s main organ for removing toxins, among other functions. The Experimental Biology 2018 meeting (EB 2018) will feature important research announcements related to the causes of liver degradation and possible treatments.

Released:
16-Apr-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites

Article ID: 693059

Transplanted Livers Help Body Defend Against Organ Rejection, Mayo Clinic Study Finds

Mayo Clinic

For decades, transplant experts have observed that liver transplant recipients often need less anti-rejection medication, known as immunosuppressive drugs, than recipients of other solid organs. Similarly, when patients receive a multiple-organ transplant that includes the liver along with any other organ, they need less immunosuppressive medication and have less incidence of rejection even if they are highly sensitive to cellular bad actors, known as antigens, from the donor organs.

Released:
18-Apr-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 692951

Could Statins Ease Deadly Heart Condition in Rare Neuromuscular Disease?

Perelman School of Medicine at the University of Pennsylvania

In preclinical studies using cell models that mimicked liver cells of patients with the rare disease Friedreich’s ataxia (FA), a widely used cholesterol-lowering drug increased a precursor of HDL (high-density lipoprotein), the “good cholesterol.” Decreased HDL and ApoA-l levels in the general population are associated with an increased risk of death from cardiomyopathy and heart failure. Researchers found the FA patients had serum ApoA-I levels lower than healthy control subjects.

Released:
17-Apr-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 692787

ASIP Gold-Headed Cane Awarded to Janardan K. Reddy, MD

Federation of American Societies for Experimental Biology (FASEB)

Dr. Janardan K. Reddy, Professor Emeritus of Pathology at Northwestern University, is this year’s recipient of the American Society for Investigative Pathology (ASIP) Gold-Headed Cane Award.

Released:
16-Apr-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites

Showing results

110 of 50





Chat now!